View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Symrise AG: 1 director

A director at Symrise AG bought 1,100 shares at 82.649EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Michael B. Schäfer
  • Michael B. Schäfer
Michael B. Schäfer
  • Michael B. Schäfer
 PRESS RELEASE

EQS-News: Symrise erhöht Dividende und bekräftigt Ausblick

EQS-News: Symrise AG / Schlagwort(e): Jahresergebnis Symrise erhöht Dividende und bekräftigt Ausblick 27.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung — Holzminden, 27. März 2025                       Symrise erhöht Dividende und bekräftigt Ausblick    Dividendenvorschlag von 1,20 € je Aktie (2023: 1,10 €) - 15. Erhöhung in Folge Symrise bekräftigt Jahresziele 2025: Organisches Wachstum von 5-7 % Die Profitabilität (EBITDA-Marge) soll um die 21 % betragen Vertrag von Dr. Stephanie Coßmann...

 PRESS RELEASE

EQS-News: Symrise raises dividend and confirms outlook

EQS-News: Symrise AG / Key word(s): Annual Results Symrise raises dividend and confirms outlook 27.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release — Holzminden, March 27, 2025                       Symrise raises dividend and confirms outlook   Dividend proposal of € 1.20 per share (2023: € 1.10) – 15th increase in succession Symrise confirms targets for 2025: Organic growth of 5-7 % Profitability (EBITDA margin) of around 21 % expected Executive Board contract of Dr. Stephanie Cossmann extended ah...

 PRESS RELEASE

EQS-News: Symrise accelerates in Human Health and Pet Nutrition throug...

EQS-News: Symrise AG / Key word(s): Agreement Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC 21.02.2025 / 10:15 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release — Holzminden, 21 February 2025 Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC This partnership ideally complements Symrise’s current portfolio with clinically proven marine ingredients HBC, a leading manufacturer of human grade, sustainable marine proteins, collagens and oi...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch